Evaxion A (EVAX) Enterprise Value (2019 - 2026)
Evaxion A (EVAX) posted Enterprise Value of -$18.4 million for Q1 2026, up 20.63% on a QoQ basis from -$23.2 million in Q4 2025, and down 3.35% year-over-year from -$19.1 million in Q1 2025.
Evaxion A (EVAX) Enterprise Value (2019 - 2026) Analysis & Trends
Evaxion A's Enterprise Value history runs 8 years deep, the most recent figure standing at -$18.4 million for Q1 2026.
- Quarterly Enterprise Value fell 3.35% year-over-year to -$18.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$18.4 million (down 3.35% YoY) and the FY2025 annual result came in at -$23.2 million, down 290.36% from the prior year.
- Enterprise Value was -$18.4 million for Q1 2026 at Evaxion A, up from -$23.2 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11731.0 in Q1 2024 and bottomed at -$31.4 million in Q1 2022.
- A 5-year average of -$13.3 million and a median of -$11.9 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value soared 99.89% — and 2025, when it tumbled 152001.27%.
- Evaxion A's Enterprise Value stood at -$13.2 million in 2022, then jumped by 57.65% to -$5.6 million in 2023, then slipped by 6.61% to -$6.0 million in 2024, then slumped by 290.36% to -$23.2 million in 2025, then climbed by 20.63% to -$18.4 million in 2026.
- Business Quant data shows EVAX's Enterprise Value at -$18.4 million in Q1 2026, -$23.2 million in Q4 2025, and -$10.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | -18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.44 Mn |
| Dec 31, 2025 | -23.23 Mn |
| Sep 30, 2025 | -10.57 Mn |
| Jun 30, 2025 | -14.75 Mn |
| Mar 31, 2025 | -17.84 Mn |
| Dec 31, 2024 | -5.95 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | -11,731.00 |
| Dec 31, 2023 | -5.58 Mn |
| Sep 30, 2023 | -2.61 Mn |
| Jun 30, 2023 | -7.12 Mn |
| Mar 31, 2023 | -10.24 Mn |
| Dec 31, 2022 | -13.18 Mn |
| Sep 30, 2022 | -17.85 Mn |
| Jun 30, 2022 | -25.25 Mn |
| Mar 31, 2022 | -31.41 Mn |
| Dec 31, 2021 | -32.17 Mn |
| Sep 30, 2021 | -11.94 Mn |
| Jun 30, 2021 | -18.80 Mn |
| Mar 31, 2021 | -26.96 Mn |